Evidence-based management of anticoagulant therapy: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based …
Background High-quality anticoagulation management is required to keep these narrow
therapeutic index medications as effective and safe as possible. This article focuses on the …
therapeutic index medications as effective and safe as possible. This article focuses on the …
Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation
RG Hart, LA Pearce, MI Aguilar - Annals of internal medicine, 2007 - acpjournals.org
Background: Atrial fibrillation is a strong independent risk factor for stroke. Purpose: To
characterize the efficacy and safety of antithrombotic agents for stroke prevention in patients …
characterize the efficacy and safety of antithrombotic agents for stroke prevention in patients …
Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association
JF Meschia, C Bushnell, B Boden-Albala, LT Braun… - Stroke, 2014 - Am Heart Assoc
The aim of this updated statement is to provide comprehensive and timely evidence-based
recommendations on the prevention of stroke among individuals who have not previously …
recommendations on the prevention of stroke among individuals who have not previously …
A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey
R Pisters, DA Lane, R Nieuwlaat, CB De Vos… - Chest, 2010 - Elsevier
Objective Despite extensive use of oral anticoagulation (OAC) in patients with atrial
fibrillation (AF) and the increased bleeding risk associated with such OAC use, no handy …
fibrillation (AF) and the increased bleeding risk associated with such OAC use, no handy …
Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association
LB Goldstein, CD Bushnell, RJ Adams, LJ Appel… - Stroke, 2011 - Am Heart Assoc
Background and Purpose—This guideline provides an overview of the evidence on
established and emerging risk factors for stroke to provide evidence-based …
established and emerging risk factors for stroke to provide evidence-based …
Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal Renal …
Objectives: The purpose of this study was to investigate predictors of bleeding in a cohort of
anticoagulated patients and to evaluate the predictive value of several bleeding risk …
anticoagulated patients and to evaluate the predictive value of several bleeding risk …
Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation
ML Hansen, R Sørensen, MT Clausen… - Archives of internal …, 2010 - jamanetwork.com
Background Patients with atrial fibrillation (AF) often require anticoagulation and platelet
inhibition, but data are limited on the bleeding risk of combination therapy. Methods We …
inhibition, but data are limited on the bleeding risk of combination therapy. Methods We …
2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the …
V Fuster, LE Rydén, DS Cannom, HJ Crijns… - Journal of the American …, 2011 - jacc.org
1.1. Organization of Committee and Evidence Review (UPDATED) For new or updated text,
view the 2011 Focused Update and the 2011 Update on Dabigatran. Text supporting …
view the 2011 Focused Update and the 2011 Update on Dabigatran. Text supporting …
Association of intracerebral hemorrhage among patients taking non–vitamin K antagonist vs vitamin K antagonist oral anticoagulants with in-hospital mortality
Importance Although non–vitamin K antagonist oral anticoagulants (NOACs) are
increasingly used to prevent thromboembolic disease, there are limited data on NOAC …
increasingly used to prevent thromboembolic disease, there are limited data on NOAC …
Acc/aha/esc 2006 guidelines for the management of patients with atrial fibrillation: A report of the american college of cardiology/american heart association task force …
Atrial fibrillation (AF) is the most common sustained cardiac rhythm disturbance, increasing
in prevalence with age. AF is often associated with structural heart disease, although a …
in prevalence with age. AF is often associated with structural heart disease, although a …